Telix Pharmaceuticals | TLX - Ebit

Stock Price
10.20
Daily Change
1.00 10.87%
Monthly
-14.00%
Yearly
-66.43%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD8.04M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -19.93M 12.02M Jun/2023
Polynovo AUD 840K 147K Jun/2024
PYC Therapeutics AUD -25.84M 3M Dec/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 497.6M 35.25M Dec/2025
Sonic Healthcare AUD 423.94M 80.3M Dec/2024